Geftiget 250 Mg

Name: Geftiget 250 Mg
Brand: Maheshwari Medical Agency
Price: 650 INR
Availability: InStock

Price 650 INR/ Bottle

Get a Price/Quote

MOQ : 1 Bottle

Geftiget 250 Mg Specification

Salt Composition
Gefitinib 250 mg

Dosage Form
Oral tablet

Life Span
24 months from manufacturing date

Packaging Type
Box

Origin of Medicine
India

Brand Name
Geftiget

Indication
Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR mutations

Pacakaging (Quantity Per Box)
30 tablets

Drug Type
Prescription medicine

Ingredients
Gefitinib 250 mg

Physical Form
Tablet

Function
Anti-cancer (EGFR-TKI)

Recommended For
Non-Small Cell Lung Cancer Patients

Dosage
As directed by the oncologist

Dosage Guidelines
Take once daily, with or without food, as prescribed

Suitable For
Adults

Quantity
30 tablets per box

Storage Instructions
Store below 30C, protect from light and moisture

Contraindications
Hypersensitivity to gefitinib or any excipients

Strength
250 mg per tablet

Therapeutic Class
Antineoplastic Agents

Marketed By
Cipla Healthcare

Precautions
Monitor liver function, use with caution in patients with interstitial lung disease

Prescription/Non Prescription
Prescription Required

Shape
Round, biconvex

Color
Light brown

Regulatory Approval
Approved by DCGI (India)

Side Effects
Rash, diarrhea, nausea, vomiting, loss of appetite

Administration Route
Oral

Geftiget 250 Mg Trade Information

Minimum Order Quantity
1 Bottle

Supply Ability
100 Bottles Per Week

Delivery Time
7 Days

About Geftiget 250 Mg

Experience the kingly efficacy of Geftiget 250 Mg-an unassailable prescription solution for adults diagnosed with non-small cell lung cancer (NSCLC) harboring EGFR mutations. Manufactured and marketed by Cipla Healthcare and proudly approved by DCGI, this triumphant anti-cancer oral tablet contains 250 mg Gefitinib per dose. Each light brown, round, biconvex tablet is packaged in a box of 30. Try Now-exclusive online purchase available for a limited time! Buy Online to ensure swift access and benefit from reliable Indian distribution.

Geftiget 250 Mg: Advantages & Commercial Edge

Geftiget 250 Mg offers a distinct advantage with its potent EGFR-TKI action for NSCLC patients, ensuring robust and targeted results. Its competitive edge lies in the trusted Cipla brand, DCGI certification, and availability for prompt online purchase or supply. Commercial users, such as distributors and healthcare providers, appreciate its reliability, extended shelf life, and easy administration, positioning Geftiget as a foremost choice in oncology therapeutics within the Indian domestic market.

Sample Policy, Certifications, and Supply Ability

Geftiget 250 Mg samples follow a regulated policy, ensuring only authorized prescription-based shipments. With DCGI approval, every shipped good meets stringent safety and quality benchmarks. The product is supplied widely across the domestic market with a consistently reliable supply chain maintained by Cipla Healthcare. Large-quantity orders from distributors, traders, and suppliers across India are fulfilled efficiently, supporting ongoing cancer treatment programs nationwide.

FAQ's of Geftiget 250 Mg:

Q: How should Geftiget 250 Mg be administered for optimal effect?

A: Geftiget 250 Mg should be taken orally, once daily, either with or without food, and strictly as directed by your oncologist. Adhering to the prescribed schedule ensures maximum therapeutic benefit.

Q: What are the main advantages and competitive strengths of Geftiget 250 Mg?

A: Geftiget 250 Mg stands out for its targeted anti-cancer efficacy in EGFR mutation-positive NSCLC, reputable manufacturing by Cipla, DCGI approval, and accessible online purchasing options.

Q: When is Geftiget 250 Mg indicated for cancer treatment?

A: This medicine is recommended for adults with locally advanced or metastatic non-small cell lung cancer (NSCLC) that tests positive for EGFR mutations, as determined by an oncologist.

Q: Where can I purchase Geftiget 250 Mg and is a prescription required?

A: Geftiget 250 Mg can be bought online through authorized distributors, suppliers, or pharmacies in India. A valid prescription from a licensed medical practitioner is mandatory for purchase.

Q: What precautions should be observed during the use of Geftiget 250 Mg?

A: Patients using Geftiget 250 Mg need regular liver function monitoring and should inform their doctor of any history of hypersensitivity or interstitial lung disease for safe usage.

Tell us about your requirement